FY2025 Earnings Estimate for Neogen Issued By William Blair

Neogen Co. (NASDAQ:NEOG) – Investment analysts at William Blair reduced their FY2025 earnings estimates for shares of Neogen in a note issued to investors on Monday, April 14th. William Blair analyst B. Vazquez now forecasts that the company will earn $0.31 per share for the year, down from their prior forecast of $0.32. The consensus estimate for Neogen’s current full-year earnings is $0.38 per share. William Blair also issued estimates for Neogen’s Q4 2025 earnings at $0.08 EPS, FY2026 earnings at $0.36 EPS and FY2027 earnings at $0.42 EPS.

Other analysts also recently issued research reports about the company. Piper Sandler dropped their target price on Neogen from $13.00 to $6.50 and set a “neutral” rating for the company in a research report on Monday. Guggenheim lowered their price target on Neogen from $15.00 to $13.00 and set a “buy” rating for the company in a research report on Thursday, April 10th.

Neogen Stock Down 7.1 %

NEOG stock opened at $4.60 on Wednesday. Neogen has a 1-year low of $3.87 and a 1-year high of $18.58. The stock has a market cap of $997.94 million, a price-to-earnings ratio of -2.10 and a beta of 1.57. The company has a current ratio of 3.77, a quick ratio of 2.46 and a debt-to-equity ratio of 0.33. The company’s 50 day moving average is $8.74 and its 200 day moving average is $11.76.

Neogen (NASDAQ:NEOG) last announced its quarterly earnings data on Wednesday, April 9th. The company reported $0.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.02). The firm had revenue of $221.00 million during the quarter, compared to the consensus estimate of $225.27 million. Neogen had a negative net margin of 52.12% and a positive return on equity of 2.89%. The company’s revenue was down 3.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.12 earnings per share.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Harbour Investments Inc. purchased a new position in shares of Neogen in the 4th quarter worth $27,000. Versant Capital Management Inc lifted its stake in shares of Neogen by 1,495.4% in the 1st quarter. Versant Capital Management Inc now owns 3,127 shares of the company’s stock valued at $27,000 after purchasing an additional 2,931 shares during the last quarter. Blue Trust Inc. boosted its holdings in shares of Neogen by 196.7% in the 4th quarter. Blue Trust Inc. now owns 3,368 shares of the company’s stock worth $41,000 after purchasing an additional 2,233 shares during the period. Johnson Financial Group Inc. bought a new position in shares of Neogen during the 4th quarter valued at approximately $43,000. Finally, Covestor Ltd raised its holdings in Neogen by 41.4% during the 4th quarter. Covestor Ltd now owns 4,103 shares of the company’s stock valued at $50,000 after buying an additional 1,202 shares during the period. Hedge funds and other institutional investors own 96.73% of the company’s stock.

Insider Transactions at Neogen

In other Neogen news, CAO John Patrick Moylan acquired 10,000 shares of the stock in a transaction dated Thursday, April 10th. The shares were acquired at an average cost of $5.07 per share, for a total transaction of $50,700.00. Following the completion of the transaction, the chief accounting officer now directly owns 10,000 shares of the company’s stock, valued at approximately $50,700. The trade was a ∞ increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Company insiders own 1.13% of the company’s stock.

Neogen Company Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.